SAM
CMD

Silphium Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Silphium Asset Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-10,000
Closed -$366K – 93
2014
Q2 		$366K Buy
+10,000
New +$339K 0.25% 64

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Silphium Asset Management's CMD Position: Q3 2014 in Review

Silphium Asset Management sold out of Cantel Medical Corporation (CMD) in Q3 2014, closing a stake of 10,000 shares — an estimated $366K sold.

Silphium Asset Management first reported a position in CMD in Q2 2014 and held it in 1 quarter. The position peaked at $366K in Q2 2014. 155 funds tracked by Wall St. Rank hold CMD as of Q3 2014.

  • Silphium Asset Management reported no remaining Cantel Medical Corporation position as of Q3 2014 after selling out during the quarter.
  • Silphium Asset Management sold 10,000 Cantel Medical Corporation shares in Q3 2014, an estimated $366K.
  • Silphium Asset Management first reported a position in Cantel Medical Corporation in Q2 2014 and held it in 1 quarter.
  • Silphium Asset Management's Cantel Medical Corporation position peaked at $366K in Q2 2014.
  • 155 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2014.

Based on Silphium Asset Management's 13F filing for Q3 2014, filed 30 Jan 2025.